These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20430832)

  • 1. In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy.
    Kikuchi A; Takeda A; Okamura N; Tashiro M; Hasegawa T; Furumoto S; Kobayashi M; Sugeno N; Baba T; Miki Y; Mori F; Wakabayashi K; Funaki Y; Iwata R; Takahashi S; Fukuda H; Arai H; Kudo Y; Yanai K; Itoyama Y
    Brain; 2010 Jun; 133(Pt 6):1772-8. PubMed ID: 20430832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.
    Kudo Y; Okamura N; Furumoto S; Tashiro M; Furukawa K; Maruyama M; Itoh M; Iwata R; Yanai K; Arai H
    J Nucl Med; 2007 Apr; 48(4):553-61. PubMed ID: 17401091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
    Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
    Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-Beta Radiotracer [
    Verdurand M; Levigoureux E; Lancelot S; Zeinyeh W; Billard T; Quadrio I; Perret-Liaudet A; Zimmer L; Chauveau F
    Contrast Media Mol Imaging; 2018; 2018():9165458. PubMed ID: 29551958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal change multiple system atrophy: an aggressive variant?
    Ling H; Asi YT; Petrovic IN; Ahmed Z; Prashanth LK; Hazrati LN; Nishizawa M; Ozawa T; Lang A; Lees AJ; Revesz T; Holton JL
    Mov Disord; 2015 Jun; 30(7):960-7. PubMed ID: 25854893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy.
    Miki Y; Foti SC; Hansen D; Strand KM; Asi YT; Tsushima E; Jaunmuktane Z; Lees AJ; Warner TT; Quinn N; Ling H; Holton JL
    Brain; 2020 Jun; 143(6):1798-1810. PubMed ID: 32385496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
    Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
    Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between β-amyloid deposits revealed by BF-227-PET imaging and brain atrophy detected by voxel-based morphometry-MR imaging: a pilot study.
    Maeno N
    Nucl Med Commun; 2019 Sep; 40(9):905-912. PubMed ID: 31246935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.
    Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H
    Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy.
    Lee S; Martinez-Valbuena I; Lang AE; Kovacs GG
    Neurobiol Dis; 2024 Jul; 197():106535. PubMed ID: 38761956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein binding to rab3a in multiple system atrophy.
    Dalfó E; Ferrer I
    Neurosci Lett; 2005 May 20-27; 380(1-2):170-5. PubMed ID: 15854772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
    Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
    Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
    Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
    Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course.
    Masui K; Nakata Y; Fujii N; Iwaki T
    Neuropathology; 2012 Feb; 32(1):69-76. PubMed ID: 21615514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
    Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
    Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
    Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.